236 related articles for article (PubMed ID: 4150143)
1. Drug-induced extrapyramidal syndromes.
Lader MH
J R Coll Physicians Lond; 1970 Oct; 5(1):87-98. PubMed ID: 4150143
[No Abstract] [Full Text] [Related]
2. [Neurologic and psychic complications in treatment with neuroleptics].
Gerlach J
Ugeskr Laeger; 1976 Jun; 138(27):1650-3. PubMed ID: 951778
[No Abstract] [Full Text] [Related]
3. Clinical management of acute neuroleptic-induced extrapyramidal syndromes.
Keepers GA; Casey DE
Curr Psychiatr Ther; 1986; 23():139-57. PubMed ID: 2870879
[No Abstract] [Full Text] [Related]
4. Neurological syndromes associated with antipsychotic drug use. A special report.
Freedman DX
Arch Gen Psychiatry; 1973 Apr; 28(4):463-7. PubMed ID: 4692143
[No Abstract] [Full Text] [Related]
5. Neurologic syndromes associated with antipsychotic-drug use.
N Engl J Med; 1973 Jul; 289(1):20-3. PubMed ID: 4708951
[No Abstract] [Full Text] [Related]
6. [Experience with the use of midantan for treatment and prevention of the neuroleptic syndrome].
Kamianov IM; Kupisk AG; Katsen IZ
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(8):1218-23. PubMed ID: 4149581
[No Abstract] [Full Text] [Related]
7. Neutralization of extrapyramidal side-effects with Methixene.
Maller O; Heller S
Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
[No Abstract] [Full Text] [Related]
8. Drug-induced movement disorders.
North RR
Postgrad Med; 1971 Sep; 50(3):180-5. PubMed ID: 5092993
[No Abstract] [Full Text] [Related]
9. [Letter: Tardive dyskinesia, a little-known extrapyramidal syndrome due to therapy with neuroleptics].
Berchtold P; Hinssen M; Irmscher K
Dtsch Med Wochenschr; 1974 Mar; 99(9):420-1. PubMed ID: 4151333
[No Abstract] [Full Text] [Related]
10. [Treatment of neuroleptic induced acute dystonia].
Malm U
Lakartidningen; 1969 Nov; 66(46):4714. PubMed ID: 5375330
[No Abstract] [Full Text] [Related]
11. [Drug-induced extrapyramidal symptoms].
Janzik HH
Dtsch Med Wochenschr; 1975 Mar; 100(11):555-7. PubMed ID: 1116439
[No Abstract] [Full Text] [Related]
12. Assessment of drugs in schizophrenia. Discussion on assessment of drug-induced extrapyramidal reactions.
McClelland HA
Br J Clin Pharmacol; 1976 Jun; 3(3 Suppl 2):401-3. PubMed ID: 9966
[No Abstract] [Full Text] [Related]
13. [Study of extrapyramidal manifestations induced by neuroleptics].
Bordeleau JM; Tétreault L
Rev Can Biol; 1972; 31():Suppl:247-53. PubMed ID: 4403291
[No Abstract] [Full Text] [Related]
14. Medical and legal implications of side effects from neuroleptic drugs. A round-table discussion.
Cancro R; Davis JM; Klawans H; Tancredi L
J Clin Psychiatry; 1981 Feb; 42(2):78-82. PubMed ID: 6109720
[TBL] [Abstract][Full Text] [Related]
15. [Extra-pyramidal syndrome caused by neuroleptics].
Lambert PA
Encephale; 1973; 62(1):78-105. PubMed ID: 4718697
[No Abstract] [Full Text] [Related]
16. [Late irreversible extrapyramidal syndrome following neuroleptic use].
Boucebci M
Acta Psychiatr Belg; 1972 Mar; 72(2):233-40. PubMed ID: 5056017
[No Abstract] [Full Text] [Related]
17. The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).
Marsden CD
Mod Trends Neurol; 1975; 6():141-66. PubMed ID: 127927
[No Abstract] [Full Text] [Related]
18. [Prolonged neurologic syndromes due to neuroleptic drugs and their treatment].
Deniker P; Ginestet D
Ann Med Interne (Paris); 1972; 123(8):787-9. PubMed ID: 4642195
[No Abstract] [Full Text] [Related]
19. [Extrapyramidal movement disorders arising during treatment of psychoses with drugs].
Vatsek Ia
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):453-7. PubMed ID: 4940
[No Abstract] [Full Text] [Related]
20. [Extrapyramidal symptoms during the use of neuroleptics].
Ditfurth HV
Nervenarzt; 1967 Apr; 38(4):151-5. PubMed ID: 4382350
[No Abstract] [Full Text] [Related]
[Next] [New Search]
